CORE: Cytometry and Cell Sorting Shared Resource (Cell and in vivo Biology Group) PROJECT SUMMARY Flow cytometry is an essential and broadly applicable technology for cancer research to assist with elucidating mechanisms of tumor suppressor and oncogenes, cell-cycle progression, transforming viruses, and to evaluate cancer therapies. It is also integral to studies of cancer stem cells, angiogenesis, inflammation, transcriptional regulation in tumor cells and mechanisms of DNA break and repair. The goal of the Cytometry and Cell Sorting Shared Resource (CCSSR) is to provide a wide range of cancer center investigators with access to cost-effective state-of-the-art instrumentation, expertise and training for their cell sorting and analysis needs. This technology continues to develop at a rapid pace, especially with the advent of novel tools and reagents, increased computational capacity and more cost-effective optical equipment. To keep pace with changing technologies and growth of users over the past 4 years, the CCSSR has expanded its space with new lab renovations, added a satellite facility at our affiliated Texas Childrens Hospital Cancer Center and acquired substantial upgrades of previously exsiting equipment and acquired additional new major equipment. The main facility is housed in centrally located space and is available to trained users 24 hours a day, seven days a week by key-card access. Current major instrumentation includes four fully florescence-activated cell sorters, six flow analyzers and magnetic- and microfluidic-based cell sorters. The Resource is directed by Dr. Christine Beeton and Mr. Joel Sederstrom, who have over ten and 15 years of experience in flow cytometry respectively, and is staffed by three full-time experienced flow cytometrists who perform operator-assisted cytometry, and assist users with data analysis. To ensure optimal use of services, CCSSR provides consultations, individually- tailored training, and protocols for sample preparation, flow analysis and cell sorting. This is a heavily used Shared Resource that provided service for 125 Cancer Center investigators during the last year, a substantial increase from 83 users in the first year of the CCSG award. Future plans include addition of new technologies and instrumentation for image- and mass-based cytometry that are pushing the boundaries of conventional flow cytometry and further expansion of space and research staff required for these new technologies and anticipated continued growth of CCSSR.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA125123-13
Application #
9759804
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2019-07-01
Budget End
2020-06-30
Support Year
13
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Baylor College of Medicine
Department
Type
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Creighton, Chad J (2018) The clinical applications of The Cancer Genome Atlas project for bladder cancer. Expert Rev Anticancer Ther 18:973-980
Guarducci, Cristina; Bonechi, Martina; Benelli, Matteo et al. (2018) Cyclin E1 and Rb modulation as common events at time of resistance to palbociclib in hormone receptor-positive breast cancer. NPJ Breast Cancer 4:38
Byrd, Tiara T; Fousek, Kristen; Pignata, Antonella et al. (2018) TEM8/ANTXR1-Specific CAR T Cells as a Targeted Therapy for Triple-Negative Breast Cancer. Cancer Res 78:489-500
Xing, Zhen; Zhang, Yanyan; Liang, Ke et al. (2018) Expression of Long Noncoding RNA YIYA Promotes Glycolysis in Breast Cancer. Cancer Res 78:4524-4532
Chiang, Angie C A; Fowler, Stephanie W; Savjani, Ricky R et al. (2018) Combination anti-A? treatment maximizes cognitive recovery and rebalances mTOR signaling in APP mice. J Exp Med 215:1349-1364
Szwarc, Maria M; Hai, Lan; Gibbons, William E et al. (2018) Retinoid signaling controlled by SRC-2 in decidualization revealed by transcriptomics Reproduction 156:387-395
Nguyen, Tuan M; Kabotyanski, Elena B; Dou, Yongchao et al. (2018) FGFR1-Activated Translation of WNT Pathway Components with Structured 5' UTRs Is Vulnerable to Inhibition of EIF4A-Dependent Translation Initiation. Cancer Res 78:4229-4240
Kho, Jordan; Tian, Xiaoyu; Wong, Wing-Tak et al. (2018) Argininosuccinate Lyase Deficiency Causes an Endothelial-Dependent Form of Hypertension. Am J Hum Genet 103:276-287
Liu, Yanhong; O'Brien, Jacqueline L; Ajami, Nadim J et al. (2018) Lung tissue microbial profile in lung cancer is distinct from emphysema. Am J Cancer Res 8:1775-1787
Scavuzzo, Marissa A; Hill, Matthew C; Chmielowiec, Jolanta et al. (2018) Endocrine lineage biases arise in temporally distinct endocrine progenitors during pancreatic morphogenesis. Nat Commun 9:3356

Showing the most recent 10 out of 991 publications